365 related articles for article (PubMed ID: 31551380)
1. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
2. The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions.
Brédart A; Anota A; Dick J; Cano A; De Pauw A; Kop JL; Aaronson NK; Bleiker EM; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13173. PubMed ID: 31571365
[TBL] [Abstract][Full Text] [Related]
3. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
[TBL] [Abstract][Full Text] [Related]
4. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
[TBL] [Abstract][Full Text] [Related]
6. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
[TBL] [Abstract][Full Text] [Related]
7. Patient-Centered Care in Breast Cancer Genetic Clinics.
Brédart A; Anota A; Dick J; Kuboth V; Lareyre O; De Pauw A; Cano A; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S; Kop JL
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439543
[TBL] [Abstract][Full Text] [Related]
8. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.
Eijzenga W; Aaronson NK; Kluijt I; Sidharta GN; Hahn DE; Ausems MG; Bleiker EM
BMC Cancer; 2014 Jan; 14():26. PubMed ID: 24428912
[TBL] [Abstract][Full Text] [Related]
10. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
[TBL] [Abstract][Full Text] [Related]
11. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
[TBL] [Abstract][Full Text] [Related]
13. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
Gill G; Beard C; Storey K; Taylor S; Sexton A
Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and detection of psychosocial problems in cancer genetic counseling.
Eijzenga W; Bleiker EM; Hahn DE; Van der Kolk LE; Sidharta GN; Aaronson NK
Fam Cancer; 2015 Dec; 14(4):629-36. PubMed ID: 25968807
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
Voorwinden JS; Jaspers JP
J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
[TBL] [Abstract][Full Text] [Related]
16. Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study.
Brédart A; Kop JL; Tüchler A; De Pauw A; Cano A; Dick J; Rhiem K; Devilee P; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S
Eur J Hum Genet; 2022 Sep; 30(9):1067-1075. PubMed ID: 35399119
[TBL] [Abstract][Full Text] [Related]
17. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE
Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347
[TBL] [Abstract][Full Text] [Related]
20. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
Esteban I; Vilaró M; Adrover E; Angulo A; Carrasco E; Gadea N; Sánchez A; Ocaña T; Llort G; Jover R; Cubiella J; Servitja S; Herráiz M; Cid L; Martínez S; Oruezábal-Moreno MJ; Garau I; Khorrami S; Herreros-de-Tejada A; Morales R; Cano JM; Serrano R; López-Ceballos MH; González-Santiago S; Juan-Fita MJ; Alonso-Cerezo C; Casas A; Graña B; Teulé A; Alba E; Antón A; Guillén-Ponce C; Sánchez-Heras AB; Alés-Martínez JE; Brunet J; Balaguer F; Balmaña J
Psychooncology; 2018 Jun; 27(6):1530-1537. PubMed ID: 29498768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]